INITS GROUP

Founded in 2013 and headquartered in Montpellier, France, INITS is a pharmaceutical development and biomanufacturing services company supporting biotech and life sciences companies developing new therapeutic products. With more than 12 years of experience and over 250 clients supported in France and internationally, INITS provides expertise across biologics (cell and gene therapies, extracellular vesicles, antibodies and proteins) as well as small and large molecules. Its team of more than 40 experts supports the full range of pharmaceutical development activities, including CMC development, Regulatory Affairs, Clinical Supply, Quality Assurance and GMP audits. INITS is also developing INITS SMO (Shared Manufacturing Organization), a 3,200 m² GMP biomanufacturing facility dedicated to the production of biologics and advanced therapies and scheduled to become operational in Q2 2026. The facility will enable biotech and pharmaceutical companies to manufacture clinical-trial batches using INITS’ GMP infrastructure, equipment and expert support while retaining full control of their processes and intellectual property. Services will include Drug Substance manufacturing, Drug Product manufacturing, fill & finish, packaging, product release and clinical supply. For more information about INITS, visit https://inits.fr.